Lycopene for Advanced Hormone Refractory Prostate Cancer: A Prospective, Open Phase II Pilot Study-Reference-Cited by-同舟云学术

Lycopene for Advanced Hormone Refractory Prostate Cancer: A Prospective, Open Phase II Pilot Study

Published:2009-03 Issue:3 Volume:181 Page:1098-1103
ISSN:0022-5347
Container-title:Journal of Urology
language:en
Short-container-title:Journal of Urology

Author:

Schwenke Carla¹,Ubrig Burkhard¹,Thürmann Petra¹,Eggersmann Christian¹,Roth Stephan¹

Affiliation:

1. Departments of Urology and Paediatric Urology and Philipp-Klee-Institute for Clinical Pharmacology (PT), Witten/Herdecke University, Witten and Helios-Hospital of Wuppertal, Wuppertal, Germany

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Urology

Reference19 articles.

1. Systemic treatment and new developments in advanced prostate cancer;Sternberg;Eur J Cancer,2001

2. Response of hormone-refractory prostate cancer to lycopene;Matlaga;J Urol,2001

3. Intake of carotenoids and retinol in relation to risk of prostate cancer;Giovannucci;J Natl Cancer Inst,1995

4. Simultaneous determination of retinol, tocopherols, carotene, lycopene, and xanthophylls in plasma by means of reversed-phase high-performance liquid chromatography;Aebischer;Meth Enzymol,1999

5. Criteria for response to treatment of metastatic prostatic cancer;Newling;Prog Clin Biol Res,1985

Cited by 27 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A phase I study of docetaxel plus synthetic lycopene in metastatic prostate cancer patients;Clinical and Translational Medicine;2024-03

2. The influence of lifestyle changes (diet, exercise and stress reduction) on prostate cancer tumour biology and patient outcomes: A systematic review;BJUI Compass;2023-04-06

3. The Anti-Cancer Activity of Lycopene: A Systematic Review of Human and Animal Studies;Nutrients;2022-12-03

4. Anti-prostate cancer protection and therapy in the framework of predictive, preventive and personalised medicine — comprehensive effects of phytochemicals in primary, secondary and tertiary care;EPMA Journal;2022-07-08

5. A phase II study of docetaxel plus lycopene in metastatic castrate resistant prostate cancer;Biomedicine & Pharmacotherapy;2021-11